| Ytd | 18.25% | |
| 1y | 16.61% |
| Open | 216.08 | Prev Close | 217.38 | Low | 215.50 | High | 219.73 | Mkt Cap | 12.55B |
| Vol | 75.43K | Avg Vol | 537.64K | EPS | 6.31 | P/E | 34.45 | Forward P/E | 32.26 |
| Beta | N/A | Short Ratio | 2.62 | Inst. Own | 77.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 05-29 | Earning | 07-28 | 50-d Avg | 200.26 | 200-d Avg | 190.68 | 1yr Est | 224.78 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
Top analysts changed outlook on top names. For all changes, incl. upgrades/downgrades/initiations, s
BMO Capital analyst Daniel DiCicco initiates coverage on Crane (NYSE:CR) with a Outperform rating
Shares of Crane (NYSE: CR - Get Free Report) have earned a consensus recommendation of "Buy" from th
WALTHAM, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in aut
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and tele
Vancouver, British Columbia – TheNewswire - June 29, 2026: Headwater Gold Inc. (CSE: HWG) (OTCQX: HW
NEW YORK, June 18, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "C
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-vi
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcorita
Investors need to pay close attention to CR stock based on the movements in the options market latel
ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today annou
On May 15, 2026, Crane Co (CR) shares fell 4.1% to a current price of $172.19. This decline comes in
Crane NXT NYSE: CXT reported first-quarter 2026 sales growth and reaffirmed its earnings outlook whi
Completes Acquisition of Antares Vision, a Global Leader in Inspection, Detection, and Track & Trace
On May 01, 2026, Crane Co (CR) shares fell 3.1% to $172.24. This decline comes amid a 52-week tradin
Top analysts downgraded APPN and XOMA stocks. Visit analyst ratings page to see other views. Should
Top analysts change outlook on top names, including upgrades, downgrades, and initiations. Check out
Top Wall Street analysts upgraded BLKB, XMTR, ECG stocks and changed price targets. See what other a
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform rating
Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. P
Analysts upgraded Qiagen, Armstrong World, T-Mobile, Crane Co, and Centene Corp stocks, with price t
Analysts change outlook & ratings for QGEN, AWI, CR, ATEN, PLUG, SBUX, CECO, CNC. Price targets
Stifel analyst Nathan Jones upgrades Crane (NYSE:CR) from Hold to Buy and raises the price target
Crane Company (CR) Q1 2026 Earnings Call Transcript
Crane Holdings (NYSE:CR) reported quarterly earnings of $1.65 per share which beat the analyst conse
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE:CR) today announced its financial res
Crane Company (NYSE: CR) today announced the completion of its previously disclosed CEO succession p
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) today announced the completion of its pre
Crane (NYSE: CR - Get Free Report) and EnWave (OTCMKTS:NWVCF - Get Free Report) are both industrials
State of Alaska Department of Revenue lowered its stake in shares of Crane (NYSE: CR) by 54.5% durin
Crane Company remains rated a soft "Sell" due to high absolute valuation despite strong operational
Crane Company ("Crane," NYSE: CR) today announced its financial results for the fourth quart
Crane Company ("Crane," NYSE: CR) today announced its financial results for the fourth quart
Crane Holdings (NYSE:CR) reported quarterly earnings of $1.53 per share which beat the analyst conse
Jim Cramer recommended holding Texas Instruments (TXN) on CNBC's Mad Money, supported by an anal
Baker Hughes (NASDAQ:BKR, "the Company"))), an energy technology company, announced Monday t
DA Davidson analyst Matt Summerville maintains Crane (NYSE:CR) with a Buy and raises the price ta
Crane (NYSE:CR) raises FY2025 Adj EPS guidance from $5.50-$5.80 to $5.75-$5.95 vs $5.77 analyst esti
Crane Holdings (NYSE:CR) reported quarterly earnings of $1.64 per share which beat the analyst conse
Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterl